Brief: Nextcell Pharma Q2 Operating Loss Widens To SEK 10.2 Million
28/04/2022 07:14
April 28 (Reuters) - NextCell Pharma AB NXTCL.ST :
* NEXTCELL PHARMA PUBLISHES INTERIM REPORT 2 2021/2022
* Q2 OPERATING REVENUE SEK 1.8 MILLION VERSUS SEK 1.0
MILLION YEAR
AGO
* Q2 OPERATING RESULT LOSS SEK 10.2 MILLION VERSUS LOSS SEK
8.1
MILLION YEAR AGO
Source text for Eikon: ID:nWkr2FlcMW
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln